Xencor Inc (XNCR) bonds
XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)
Close on Nov 18, 2026Market cap $2.56BP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$104.90M
$27.36M due within a year
Net debt
$60.23M
After $44.66M of cash
Implied interest rate
22.53%
FY2025 interest ÷ average debt
Interest coverage
-5.6×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in Xencor's 10-Q for the period ended Aug 31, 2023
Xencor's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Letter of Credit | $400.00K |
See a number that looks wrong?